The Life Science business of Merck KGaA, Darmstadt, Germany Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
HUB Organoids official news RSS · 行業原文收錄 · 來源發佈：Mon Jan 06 2025 13:23:34 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Reinforces company’s commitment to differentiated solutions that enable faster and more effective drug development HUB’s organoid offering complements company’s cell culture portfolio of media, reagents, and benchtop instrumentation Organoids provide drug response data earlier in the development process while helping to maintain project scale Darmstadt, Germany, January 6, 2025 – The Life Science
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。